An AI model that ranks well on a benchmark and an AI model that changes a project decision are not the same thing. Closing that gap is the subject of this week's panel at Discovery on Target.
Victor Sebastian Perez, PhD, Head of Computational Drug Design, EMEA from SandboxAQ, joins the panel discussion Bridging AI/ML Tools and Real-World Drug Discovery — Thursday 1 October, 9:35 AM ET.
With all the recent drug discovery advancements, we can now generate molecules, structures, antibodies, and hypotheses at unprecedented scale. Victor Sebastian Perez will discuss the opportunity now to build intelligent, closed-loop discovery systems that combine models with biological context, experimental data, and active learning to decide what to make, test, and pursue next.
Attending Cambridge Healthtech Institute’s Innovative Discovery Technologies conference? Find Víctor on Thursday morning.